- Previous: Recent Findings Present New Strategy to Fight Hepatitis C
- Main
- Next: Living with Hepatitis C: Is an Occasional Drink Okay?
Boceprevir Trial Delivers Hopeful News for Hepatitis C
October 24, 2007
Preliminary results from a Phase II trial on Schering-Plough's experimental Hepatitis C drug Boceprevir are promising. If the results of this study prove to be reproducible and the drug is safe, Boceprevir may help many more people defeat the Hepatitis C virus.
Schering says data on hepatitis C drug promising
NEW YORK, Oct 18 (Reuters) - Schering-Plough Corp (SGP.N: Quote, Profile, Research) on Thursday reported promising early results from a mid-stage study involving its experimental hepatitis C drug, boceprevir.
The company said the favorable results were seen in a Phase II trial of patients who had never previously been treated for their infections with the liver-damaging hepatitis C virus.
One group of patients received boceprevir along with Schering-Plough's widely used current dual therapy -- the injectable interferon drug Peg-Intron and anti-viral pill ribavirin -- while another group received only Peg-Intron and ribavirin.
After 12 weeks of treatment, up to 79 percent of patients in the boceprevir group had undetectable levels of the virus in their bloodstreams, compared with 34 percent of those taking only Peg-Intron and ribavirin.
The company noted that the results, although encouraging, were only preliminary. (Reporting by Lewis Krauskopf and Ransdell Pierson, editing by Gerald E. McCormick)
Posted by Editors at October 24, 2007 1:41 PM
Site Topics
HCV Symptoms
You'll find links to a comprehensive symptoms list, as well as various studies and discussions about Hepatitis C symptoms.
Lab Tests
What they are and what they mean. Helps you interpret & understand all the various hepatitis lab tests likely to be encountered.
Hepatitis C Genotypes
Learn about Hepatitis C Genotypes and their variants.
Viral Load
Includes a convenient Viral Load chart, as well as a link to a detailed discussion on how to analyze and interpret viral load numbers.
What is...?
Learn more about various Hepatitis C related topics, including HCV, Ascites, Biopsies, and much more.
HCV Medicines
Numerous links to studies, info sheets, FAQs, and analysis of Ribavirin/Rebetron medicines.
Hepatitis C Doctors
A state-by-state and worldwide reference listing physicians who treat HCV, including an email link to submit your physician for inclusion.
Biopsy Info
A comprehensive resource of information relating to the liver biopsy.
Cirrhosis
Many discussions and analyses of cirrhosis, including causes, complications, pathology, symptoms, and much more.
Liver Cancer
Liver Cancer/Hepatocellular Carcinoma studies, info sheets, FAQs, and analysis.
Liver Disease Medicines
An exhaustive list of links to studies, info sheets, FAQs, and analysis of the various drugs used to treat liver disease.
Hep-Central Email List
Sign up to learn about advances and breakthroughs in Hepatitis C research, including information about medical and complementary treatments.
HCV Links
Convenient links to other sites external to Hepatitis-Central.
Mother/Child Transmission
Discussions of the special problems and precautions necessary involving mother to child transmission of Hepatitis C.
HCV Natural Remedies
A number of herbal products useful in the management of liver disease.
HCV Books
Recommended reading for those interested in hepatitis information.
Hepatitis C Forum
A Bulletin Board for discussions on hepatitis, treatments, etc.
Hepatitis C Activism
An easy way to get involved in urging our government to do more for Hepatitis C awareness and treatment research.
Advertisement
Advertisement
Site Topics
HCV Symptoms, Lab Tests, Hepatitis C Genotypes, Glossary, Viral Load, What is...?, HCV Medicines, Hepatitis C Doctors, Biopsy Info, Cirrhosis, Liver Cancer, Liver Disease Medicines, Hep-Central Email List, HCV Links, Mother / Child Transmission, HCV Natural Remedies, HCV Books, Hepatitis C Forum, Hepatitis C Activism
Copyright ©1994-2010 Hepatitis Central. Information at this website is for educational purposes only; statements about products and health conditions have not been evaluated by the U.S. Food & Drug Administration.